Advertisement

DOD Prostate Cancer Research Program opportunities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The FY18 Defense Appropriations Act provides $100 million to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.

FY18 PCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.

Applications submitted to the FY18 PCRP must addresses one or more of the Overarching Challenges (revised for FY18):

  • Develop treatments that improve outcomes for men with lethal prostate cancer

  • Reduce lethal prostate cancer in African Americans, Veterans, and other high-risk populations

  • Define the biology of lethal prostate cancer to reduce death

  • Improve the quality of life for survivors of prostate cancer

http://cdmrp.army.mil/funding/pcrp


Health Disparity Research Award

Advertisement

Letter of Intent due Sept. 20


Health Disparity Scholar Award

Letter of Intent due Sept. 20


A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal at https://eBRAP.org prior to the pre-application deadline.

All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.

Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Advertisement
Advertisement